Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic

Detalhes bibliográficos
Autor(a) principal: Sousa, Myrelle Leal Campos
Data de Publicação: 2023
Outros Autores: Targino Firmino, Ramon, Gomes, Rafael Domingos Almeida Durand, Nunes, Wanúbia Barbosa, Perazzo, Matheus França, Paiva, Saul Martins, Granville-Garcia, Ana Flávia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da ABENO (Online)
DOI: 10.30979/revabeno.v23i1.2170
Texto Completo: https://revabeno.emnuvens.com.br/revabeno/article/view/2170
Resumo: The present study assessed the prevalence of the use of anxiolytics/antidepressants and associated factors among university students in the pre-vaccine period of the COVID-19 pandemic. A cross-sectional study was conducted with 983 students of public and private universities in Brazil. Data were collected between September and December 2020 with the aid of a questionnaire available on the Survey Monkey® platform addressing socioeconomic data, self-rated health, the use of anxiolytics/antidepressants, history of depression, psychological/psychiatric treatment and aspects of the undergraduate course. Statistical analysis involved descriptive statistics and Poisson regression with robust variance (α = 5%). The prevalence of anxiolytics/antidepressants use was 15.7%. The use of anxiolytics/antidepressants was associated with the female sex (PR = 1.53; 95% CI: 1.03-2.26), dissatisfaction with one’s overall health (PR = 1.40; 95% CI: 1.08-1.82), undergoing psychological/psychiatric treatment (PR = 2.85; 95% CI: 1.91-4.22) and a medical diagnosis of depression (PR = 3.44; 95% CI: 2.52-4.70). The female sex, dissatisfaction with one’s own overall health status, undergoing psychological/psychiatric treatment and a medical diagnosis of depression exerted an influence on the use of anxiolytics/antidepressants by undergraduate university students during the COVID-19 pandemic.
id ABENO-2_e034353541253d27f1323d60f7be5132
oai_identifier_str oai:ojs.revabeno.emnuvens.com.br:article/2170
network_acronym_str ABENO-2
network_name_str Revista da ABENO (Online)
spelling Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemicUso de ansiolíticos/antidepresivos por estudiantes universitarios en el periodo prevacuna en la pandemia COVID-19Uso de ansiolíticos/antidepressivos por estudantes universitários em período pré-vacina na pandemia da COVID-19Anti-Anxiety Agents Antidepressive AgentsCOVID-19PandemicsUniversitiesAnsiolíticos AntidepresivosCOVID-19PandemiasUniversidadesAnsiolíticosAntidepressivosCOVID-19PandemiasUniversidadesThe present study assessed the prevalence of the use of anxiolytics/antidepressants and associated factors among university students in the pre-vaccine period of the COVID-19 pandemic. A cross-sectional study was conducted with 983 students of public and private universities in Brazil. Data were collected between September and December 2020 with the aid of a questionnaire available on the Survey Monkey® platform addressing socioeconomic data, self-rated health, the use of anxiolytics/antidepressants, history of depression, psychological/psychiatric treatment and aspects of the undergraduate course. Statistical analysis involved descriptive statistics and Poisson regression with robust variance (α = 5%). The prevalence of anxiolytics/antidepressants use was 15.7%. The use of anxiolytics/antidepressants was associated with the female sex (PR = 1.53; 95% CI: 1.03-2.26), dissatisfaction with one’s overall health (PR = 1.40; 95% CI: 1.08-1.82), undergoing psychological/psychiatric treatment (PR = 2.85; 95% CI: 1.91-4.22) and a medical diagnosis of depression (PR = 3.44; 95% CI: 2.52-4.70). The female sex, dissatisfaction with one’s own overall health status, undergoing psychological/psychiatric treatment and a medical diagnosis of depression exerted an influence on the use of anxiolytics/antidepressants by undergraduate university students during the COVID-19 pandemic. El presente estudio evaluó la prevalencia del uso de ansiolíticos/antidepresivos y factores asociados entre estudiantes universitarios en el período previo a la vacunación de la pandemia COVID-19. Se realizó un estudio transversal con 983 estudiantes de universidades públicas y privadas de Brasil. Los datos fueron recolectados entre septiembre y diciembre de 2020 con la ayuda de un cuestionario disponible en la plataforma Survey Monkey® que aborda datos socioeconómicos, salud autoevaluada, uso de ansiolíticos/antidepresivos, antecedentes de depresión, tratamiento psicológico/psiquiátrico y aspectos de la carrera universitaria. curso. El análisis estadístico implicó estadística descriptiva y regresión de Poisson con varianza robusta (α = 5%). La prevalencia del uso de ansiolíticos/antidepresivos fue del 15,7%. El uso de ansiolíticos/antidepresivos se asoció con el sexo femenino (RP = 1,53; IC 95%: 1,03-2,26), insatisfacción con la salud general (RP = 1,40; IC 95%: 1,08-1,82), estar sometido a tratamiento psicológico/psiquiátrico (RP = 2,85; IC 95%: 1,91-4,22) y diagnóstico médico de depresión (RP = 3,44; IC 95%: 2,52-4,70). El sexo femenino, la insatisfacción con el propio estado de salud general, el tratamiento psicológico/psiquiátrico y el diagnóstico médico de depresión influyeron en el uso de ansiolíticos/antidepresivos por parte de estudiantes universitarios durante la pandemia de COVID-19.O presente estudo avaliou a prevalência do uso de ansiolíticos/antidepressivos e fatores associados entre estudantes universitários no período pré-vacinal da pandemia de COVID-19. Foi realizado um estudo transversal com 983 estudantes de universidades públicas e privadas do Brasil. Os dados foram coletados entre setembro e dezembro de 2020 com auxílio de questionário disponível na plataforma Survey Monkey® abordando dados socioeconômicos, autoavaliação de saúde, uso de ansiolíticos/antidepressivos, histórico de depressão, tratamento psicológico/psiquiátrico e aspectos da graduação curso. A análise estatística envolveu estatística descritiva e regressão de Poisson com variância robusta (α = 5%). A prevalência de uso de ansiolíticos/antidepressivos foi de 15,7%. O uso de ansiolíticos/antidepressivos esteve associado ao sexo feminino (RP = 1,53; IC 95%: 1,03-2,26), insatisfação com a saúde geral (RP = 1,40; IC 95%: 1,08-1,82), estar em tratamento psicológico/psiquiátrico (RP = 2,85; IC 95%: 1,91-4,22) e diagnóstico médico de depressão (RP = 3,44; IC 95%: 2,52-4,70). O sexo feminino, a insatisfação com o próprio estado geral de saúde, a realização de tratamento psicológico/psiquiátrico e o diagnóstico médico de depressão exerceram influência no uso de ansiolíticos/antidepressivos por estudantes universitários de graduação durante a pandemia de COVID-19.Associação Brasileira de Ensino Odontológico2023-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revabeno.emnuvens.com.br/revabeno/article/view/217010.30979/revabeno.v23i1.2170Revista da ABENO; Vol. 23 No. 1 (2023); 2170Revista da ABENO; Vol. 23 Núm. 1 (2023); 2170Revista da ABENO; v. 23 n. 1 (2023); 21702595-02741679-5954reponame:Revista da ABENO (Online)instname:Associação Brasileira de Ensino Odontológico (ABENO)instacron:ABENOenghttps://revabeno.emnuvens.com.br/revabeno/article/view/2170/1401http://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessSousa, Myrelle Leal CamposTargino Firmino, RamonGomes, Rafael Domingos Almeida DurandNunes, Wanúbia BarbosaPerazzo, Matheus FrançaPaiva, Saul MartinsGranville-Garcia, Ana Flávia2024-01-23T11:49:33Zoai:ojs.revabeno.emnuvens.com.br:article/2170Revistahttps://revabeno.emnuvens.com.br/revabeno/indexONGhttps://revabeno.emnuvens.com.br/revabeno/oairevabeno@gmail.com2595-02741679-5954opendoar:2024-01-23T11:49:33Revista da ABENO (Online) - Associação Brasileira de Ensino Odontológico (ABENO)false
dc.title.none.fl_str_mv Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
Uso de ansiolíticos/antidepresivos por estudiantes universitarios en el periodo prevacuna en la pandemia COVID-19
Uso de ansiolíticos/antidepressivos por estudantes universitários em período pré-vacina na pandemia da COVID-19
title Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
spellingShingle Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
Sousa, Myrelle Leal Campos
Anti-Anxiety Agents
Antidepressive Agents
COVID-19
Pandemics
Universities
Ansiolíticos
Antidepresivos
COVID-19
Pandemias
Universidades
Ansiolíticos
Antidepressivos
COVID-19
Pandemias
Universidades
Sousa, Myrelle Leal Campos
Anti-Anxiety Agents
Antidepressive Agents
COVID-19
Pandemics
Universities
Ansiolíticos
Antidepresivos
COVID-19
Pandemias
Universidades
Ansiolíticos
Antidepressivos
COVID-19
Pandemias
Universidades
title_short Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
title_full Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
title_fullStr Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
title_full_unstemmed Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
title_sort Use of anxiolytics/antidepressants among university students in the pre-vaccine period of the COVID-19 pandemic
author Sousa, Myrelle Leal Campos
author_facet Sousa, Myrelle Leal Campos
Sousa, Myrelle Leal Campos
Targino Firmino, Ramon
Gomes, Rafael Domingos Almeida Durand
Nunes, Wanúbia Barbosa
Perazzo, Matheus França
Paiva, Saul Martins
Granville-Garcia, Ana Flávia
Targino Firmino, Ramon
Gomes, Rafael Domingos Almeida Durand
Nunes, Wanúbia Barbosa
Perazzo, Matheus França
Paiva, Saul Martins
Granville-Garcia, Ana Flávia
author_role author
author2 Targino Firmino, Ramon
Gomes, Rafael Domingos Almeida Durand
Nunes, Wanúbia Barbosa
Perazzo, Matheus França
Paiva, Saul Martins
Granville-Garcia, Ana Flávia
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sousa, Myrelle Leal Campos
Targino Firmino, Ramon
Gomes, Rafael Domingos Almeida Durand
Nunes, Wanúbia Barbosa
Perazzo, Matheus França
Paiva, Saul Martins
Granville-Garcia, Ana Flávia
dc.subject.por.fl_str_mv Anti-Anxiety Agents
Antidepressive Agents
COVID-19
Pandemics
Universities
Ansiolíticos
Antidepresivos
COVID-19
Pandemias
Universidades
Ansiolíticos
Antidepressivos
COVID-19
Pandemias
Universidades
topic Anti-Anxiety Agents
Antidepressive Agents
COVID-19
Pandemics
Universities
Ansiolíticos
Antidepresivos
COVID-19
Pandemias
Universidades
Ansiolíticos
Antidepressivos
COVID-19
Pandemias
Universidades
description The present study assessed the prevalence of the use of anxiolytics/antidepressants and associated factors among university students in the pre-vaccine period of the COVID-19 pandemic. A cross-sectional study was conducted with 983 students of public and private universities in Brazil. Data were collected between September and December 2020 with the aid of a questionnaire available on the Survey Monkey® platform addressing socioeconomic data, self-rated health, the use of anxiolytics/antidepressants, history of depression, psychological/psychiatric treatment and aspects of the undergraduate course. Statistical analysis involved descriptive statistics and Poisson regression with robust variance (α = 5%). The prevalence of anxiolytics/antidepressants use was 15.7%. The use of anxiolytics/antidepressants was associated with the female sex (PR = 1.53; 95% CI: 1.03-2.26), dissatisfaction with one’s overall health (PR = 1.40; 95% CI: 1.08-1.82), undergoing psychological/psychiatric treatment (PR = 2.85; 95% CI: 1.91-4.22) and a medical diagnosis of depression (PR = 3.44; 95% CI: 2.52-4.70). The female sex, dissatisfaction with one’s own overall health status, undergoing psychological/psychiatric treatment and a medical diagnosis of depression exerted an influence on the use of anxiolytics/antidepressants by undergraduate university students during the COVID-19 pandemic.
publishDate 2023
dc.date.none.fl_str_mv 2023-11-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revabeno.emnuvens.com.br/revabeno/article/view/2170
10.30979/revabeno.v23i1.2170
url https://revabeno.emnuvens.com.br/revabeno/article/view/2170
identifier_str_mv 10.30979/revabeno.v23i1.2170
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://revabeno.emnuvens.com.br/revabeno/article/view/2170/1401
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Ensino Odontológico
publisher.none.fl_str_mv Associação Brasileira de Ensino Odontológico
dc.source.none.fl_str_mv Revista da ABENO; Vol. 23 No. 1 (2023); 2170
Revista da ABENO; Vol. 23 Núm. 1 (2023); 2170
Revista da ABENO; v. 23 n. 1 (2023); 2170
2595-0274
1679-5954
reponame:Revista da ABENO (Online)
instname:Associação Brasileira de Ensino Odontológico (ABENO)
instacron:ABENO
instname_str Associação Brasileira de Ensino Odontológico (ABENO)
instacron_str ABENO
institution ABENO
reponame_str Revista da ABENO (Online)
collection Revista da ABENO (Online)
repository.name.fl_str_mv Revista da ABENO (Online) - Associação Brasileira de Ensino Odontológico (ABENO)
repository.mail.fl_str_mv revabeno@gmail.com
_version_ 1822178878001512448
dc.identifier.doi.none.fl_str_mv 10.30979/revabeno.v23i1.2170

Registros relacionados